Heather Haye

Statistics

Publications

Citations

568

H-Index

Active since

2008

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Heather Haye is an author at AstraZeneca (United States) specializing in molecular oncology, checkpoint kinase inhibition, and checkpoint inhibitor therapy.

Publications per year

2008–2010

Publications

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

Sonya Zabludoff, Chun Deng, Michael Grondine et al. · Molecular Cancer Therapeutics · 2008 · 410 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Changing patterns of bleeding in patients with severe haemophilia A

David Stephensen, Robert C. Tait, N. Brodie et al. · Haemophilia · 2009 · 145 citations

Medicine, Hematology, Hemostasis +9

Discovery of a novel class of triazolones as Checkpoint Kinase inhibitors—Hit to lead exploration

Vibha Oza, Susan Ashwell, Patrick Brassil et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

1–3 of 3